- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- A company based in Sunnyvale sought FDA approval for therapies and held a conference in New York City.
LENZ Therapeutics is engaged with the FDA regarding LNZ100.
5 reports, 2 independent
Updated Jul 6
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 3
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
LENZ Therapeutics is engaged with the FDA regarding LNZ100.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Laboratoires Théa received an exclusive license for the drug LNZ100 from LENZ Therapeutics.Sub-event
LENZ Therapeutics received FDA approval and presented its product VIZZ at a conference in NYC.1 source
Ongoing discussions between LENZ Therapeutics and the FDA regarding the LNZ100 product.1 source
Keep exploring
The entities involved
- FDA
-
New York City
most populous city in the United States
Related events
- Williams led development to achieve FDA clearance.
- UroGen Pharma Ltd., headquartered in Princeton, is seeking FDA approval for its products for the U.S. market.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- OS Therapies, Inc. is seeking interim and final review data submissions from regulatory bodies while attending major global investment conferences.
Coverage
Newest first; wire copies grouped- GlobeNewswireLENZ Therapeutics to Present at Upcoming Investor and Medical Conferences SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceuti
- Simply Wall St.Will FDA Approval of Vizz Eye Drops Change LENZ Therapeutics' (LENZ) Narrative? LENZ Therapeutics recently received FDA approval for its Vizz eye drops to treat presbyopia in adults, offering a new n
- GlobeNewswireLENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a
- GlobeNewswireLENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date